Surgical resection of solitary metastases after chemotherapy in patients with nonseminomatous germ cell tumors and elevated serum tumor markers

Cancer. 1992 Nov 1;70(9):2354-7. doi: 10.1002/1097-0142(19921101)70:9<2354::aid-cncr2820700924>3.0.co;2-u.

Abstract

Background: Chemorefractory metastatic germ cell tumors and elevated tumor markers generally indicate inoperable disease.

Methods: Solitary metastases were resected in 15 patients who had a nonseminomatous germ cell tumor and an elevated alpha-fetoprotein (AFP) and/or human chorionic gonadotropin (HCG) serum level after treatment with cisplatin-based chemotherapy. Patients underwent resection for a residual mass after chemotherapy or for a new solitary metastasis after achieving a complete response (CR) to salvage chemotherapy.

Results: Seven patients were disease-free after surgical resection alone. All five patients with an elevated HCG level had a relapse after surgery compared with 3 of 10 patients with only an elevated AFP level. Only 4 of 10 patients with a retroperitoneal metastasis had a relapse after surgery compared with 4 of 5 patients with visceral disease. Eleven of 15 patients overall were disease-free after surgery and subsequent chemotherapy after a relapse.

Conclusions: Surgical resection of a solitary metastasis despite elevated serum tumor markers should be considered in patients who have not had a durable CR to cisplatin-based chemotherapy.

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Biomarkers, Tumor / blood*
  • Chemotherapy, Adjuvant
  • Chorionic Gonadotropin / blood*
  • Cisplatin / administration & dosage
  • Humans
  • Ifosfamide / administration & dosage
  • Lymphatic Metastasis
  • Neoplasm Recurrence, Local
  • Neoplasms, Germ Cell and Embryonal / blood
  • Neoplasms, Germ Cell and Embryonal / drug therapy
  • Neoplasms, Germ Cell and Embryonal / secondary*
  • Neoplasms, Germ Cell and Embryonal / surgery*
  • Prognosis
  • Remission Induction
  • Retroperitoneal Neoplasms / drug therapy
  • Retroperitoneal Neoplasms / secondary
  • Retroperitoneal Neoplasms / surgery
  • Salvage Therapy
  • Survival Rate
  • alpha-Fetoproteins / analysis*

Substances

  • Biomarkers, Tumor
  • Chorionic Gonadotropin
  • alpha-Fetoproteins
  • Cisplatin
  • Ifosfamide